Jointown Pharmaceutical Group Co Ltd (600998) — Capital Reinvestment Ratio
Jointown Pharmaceutical Group Co Ltd (600998) has a Capital Reinvestment Ratio of 0.53x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥528.22 Million) in capital expenditures (CN¥281.66 Million). Check tangible net worth ratio of Jointown Pharmaceutical Group Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jointown Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2007–2024)
This chart tracks Jointown Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see Jointown Pharmaceutical Group Co Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Jointown Pharmaceutical Group Co Ltd (2007–2024)
Year-by-year Capital Reinvestment Ratio for Jointown Pharmaceutical Group Co Ltd from 2007 to 2024. See Jointown Pharmaceutical Group Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥3.08 Billion | CN¥975.42 Million | ▲ +44.3% |
| 2023 | 0.22x | CN¥4.78 Billion | CN¥1.05 Billion | ▼ -29.7% |
| 2022 | 0.31x | CN¥3.99 Billion | CN¥1.24 Billion | ▼ -22.2% |
| 2021 | 0.40x | CN¥3.46 Billion | CN¥1.39 Billion | ▼ -5.3% |
| 2020 | 0.42x | CN¥3.44 Billion | CN¥1.46 Billion | ▼ -1.8% |
| 2019 | 0.43x | CN¥2.77 Billion | CN¥1.19 Billion | ▼ -71.0% |
| 2018 | 1.49x | CN¥1.22 Billion | CN¥1.81 Billion | ▼ -44.3% |
| 2016 | 2.67x | CN¥431.26 Million | CN¥1.15 Billion | ▲ +15.3% |
| 2015 | 2.31x | CN¥435.96 Million | CN¥1.01 Billion | ▼ -47.8% |
| 2013 | 4.43x | CN¥138.47 Million | CN¥613.81 Million | ▲ +596.5% |
| 2008 | 0.64x | CN¥494.75 Million | CN¥314.90 Million | ▼ -85.7% |
| 2007 | 4.44x | CN¥65.95 Million | CN¥293.03 Million | — |